This service offers regulatory toxicology studies in compliance with Good Laboratory Practice (GLP) to support the development of drugs, medical devices, and chemical products. The service duration varies depending on the complexity of the required studies, ranging from a few weeks to 12 months. It is targeted at pharmaceutical and biotech companies, as well as research and development institutions. The goal of the service is to provide reliable toxicological data accepted by regulatory authorities, essential for the submission of new drugs or product applications. The studies cover different phases, from preclinical characterization to safety assessment, with activities including in vitro and in vivo testing, single and repeated dose studies, and target organ toxicity evaluation. Expected outcomes include complete toxicology reports, ready for regulatory submission, ensuring compliance with international requirements. The process is carried out by an internal team of experts with extensive experience in GLP studies, guaranteeing the highest quality and scientific rigor at every stage.
With negotiable costs starting at 5000€/package.
Access to Infrastructure & R&D Support
Are you in doubt if this is the right service for you, or do you want to get more information about the service? Get in touch with the EIC Partner providing this service through this query form!
Is this the service you are looking for? If so, you can apply to the service through EIC ACCESS+! Eligible applicants can also get co-funding through the EIC ACCESS+ initiative. Find out more on the project webiste.
Receive up to €60,000 in grants, covering up to 50% of the costs, to access specialised services from the EIC Service Catalogue. Learn more on the EIC ACCESS+ website.